What Investors Should Know About the FDA Drug Approval Process

Published: May 03, 2013

The Approval Process in Action - The Life Sciences Report (5/3/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

Back to news